Undeniable Benefits of EMR Solutions Continue to Drive Growth of European EMR Markets

Frost & SullivanImproved efficiency and patient safety, better cost containment and the desire to provide integrated healthcare are some of the major factors driving the growth of the European electronic medical record (EMR) markets. EMR offers healthcare providers the opportunity to better manage patient data, create reports and work in an integrated manner, resulting in reduced costs and superior care delivery.

New analysis from Frost & Sullivan (http://healthcareandlifesciencesIT.frost.com), European Electronic Medical Records Markets, reveals that these markets earned revenues of $349.6 million in 2006 and estimates this to reach $1.15 billion in 2013.

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the latest analysis of European Electronic Medical Records Markets, then send an e-mail to Radhika Menon Theodore, Corporate Communications, at This email address is being protected from spambots. You need JavaScript enabled to view it. with your full name, company name, title, telephone number, fax number and e-mail address. Upon receipt of the above information, an overview will be sent to you by e-mail.

"Having accurate patient data plays a vital role in treating patients effectively, but this has always depended on maintaining comprehensive records of patients' encounters with the medical system," remarks Frost & Sullivan Senior Research Analyst Kiran John. "EMR provides healthcare professionals and nursing and administrative staff instant access to the right information from multiple points, and EMR data can be sourced, accessed, edited, appended and maintained effortlessly."

The cost savings potential of EMR in both primary and hospital care is perhaps the most compelling factor driving its uptake, given that cost containment is a top priority for governments and providers alike. The time and costs associated with basic but essential activities such as creating and storing charts and employing adequate nursing and administrative staff for these purposes can be reduced significantly by adopting an EMR system.

However, considering the highly fragmented nature of the European EMR markets owing to Europe's innate diversity and the varying levels of penetration of healthcare information technology (HIT), healthcare authorities are undertaking a standardisation drive in an attempt to provide better care delivery. Vendors with a European presence are particularly affected, as they need to customise or even re-invent their products and price them differently.

This has raised the question of creating unique patient identities, which many believe is critical to create a strong foundation on which EMR can be rolled out. There has been an ongoing debate about this issue and whether certification is really required for EMR solutions, and the answer will have a direct bearing on both technology adoption and solution creation.

"The need for unique patient identities is critical to the growth of any patient-centric healthcare information system but this must be initiated at a national level, which poses a significant challenge," says Mr. John. "EMR solutions tend to significantly change the care delivery process, and this brings added challenges in the form of implementation and change management issues that implementers, providers, governments and users will need to tackle."

However, the industry is expected to overcome these challenges as both primary and hospital care providers are fully aware of the benefits of EMR, which is clearly one of the most anticipated HIT solutions set to be extensively implemented across Europe. Despite the presence of restraining factors, there are many compelling drivers boosting the growth of the EMR markets at an annual rate exceeding 15.0 percent. The market holds an equally promising future for EMR vendors operating in the primary and hospital care sectors.

European Electronic Medical Records Markets is part of the Healthcare and Life Sciences IT Growth partnership Services program, which also includes research in the following markets: Healthcare IT Platforms, Patient Administration Systems in Europe, Clinical Decision Support Systems Markets in Europe, European Patient E-Booking and Healthcare Smart Cards Systems in Europe. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com.

Most Popular Now

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...

Does AI Improve Doctors' Diagnoses?

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the accuracy of doctors' diagnoses when...

AI Analysis of PET/CT Images can Predict…

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious...

500 Patient Images per Second Shared thr…

The image exchange portal, widely known in the NHS as the IEP, is now being used to share as many as 500 images each second - including x-rays, CT, MRI...

Jane Stephenson Joins SPARK TSL as Chief…

Jane Stephenson has joined SPARK TSL as chief executive as the company looks to establish the benefits of SPARK Fusion with trusts looking for deployable solutions to improve productivity. Stephenson joins...

NIH-Developed AI Algorithm Successfully …

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical research trials...

Heart Attacks could be Ruled Out Early w…

As many as 60% of people presenting to emergency departments around the world with heart attack symptoms could be safely sent home, many at earlier stages, with the support of...

Northern Ireland's Laboratory Servi…

The transformation of pathology services across Northern Ireland has achieved another milestone, with the completion of phase three of the CoreLIMS programme to deploy Clinisys WinPath to all five health...

MEDICA 2024 and COMPAMED 2024: Medical T…

11 - 14 November 2024, Düsseldorf, Germany. "Meet Health. Future. People." is MEDICA's campaign motto for the future in the new trade fair year 2025. The aptness of the motto...

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...